Biotech: Page 31


  • Image attribution tooltip
    Retrieved from Rare Disease.org.
    Image attribution tooltip
    Q&A

    For the CEO of Travere, running a rare disease company is personal

    To kick off Rare Disease month, we interview the CEO of Travere Therapeutics

    By Kim Ribbink • Feb. 1, 2022
  • Image attribution tooltip
    The image by Pixabay is licensed under CC BY 1.0
    Image attribution tooltip
    Q&A

    Foghorn's CEO on why collaborations are key to unlocking precision medicine

    With a major development deal under his belt, Adrian Gottschalk is helping the company advance its innovative platform.

    By Robin Robinson • Jan. 28, 2022
  • tech clinical trial Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Tech for Clinical Trials

    Companies that utilize these emerging technologies wisely are likely to find an edge in the increasingly competitive drug development arena.

    By PharmaVoice staff
  • Image attribution tooltip

    Permission granted by Blueprint Medicines

    Image attribution tooltip
    Profile

    Taking the leap and not having all the answers: How incoming CEO Kate Haviland plans to lead Blueprint

    For Haviland, success in biotech is about more than drug development.

    By Alexandra Pecci • Jan. 28, 2022
  • Image attribution tooltip
    Ricardo Ceppi via Getty Images
    Image attribution tooltip
    Opinion

    Biopharma's R&D leaders on how technology can accelerate drug development

    How emerging digital tools are providing enhanced clinical insights and improved trial results.

    By Jan. 27, 2022
  • Image attribution tooltip
    The image by Pixabay is licensed under CC BY 1.0
    Image attribution tooltip

    How AI is helping pharma solve some of its COVID problems

    With the pressure still on pharma to innovate quickly and go digital, the use-cases for AI are increasing in stride.

    By Jan. 25, 2022
  • headshot
    Image attribution tooltip
    Permission granted by Craig Lipset
    Image attribution tooltip
    Profile

    One man's quest to boost the patient's role in clinical trials

    How a personal diagnosis inspired Craig Lipset to transform patient involvement in medical research.

    By Robin Robinson • Jan. 24, 2022
  • man in suit patient figures magnifying glass
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip
    Opinion

    Leaders predict improving patient engagement will lead to growth opportunities

    Why patient engagement is key to successful business growth.

    By Jan. 24, 2022
  • headshot
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip
    Profile

    Evofem CEO Saundra Pelletier aims to level the playing field between men's and women's health

    Evofem CEO and PharmaVoice100, Saundra Pelletier, discusses funding challenges for women's health.

    By Alexandra Pecci • Jan. 23, 2022
  • Image attribution tooltip
    Space Frontiers via Getty Images
    Image attribution tooltip
    Profile

    Vaxxinity looks to pioneer the next revolution in pharma

    With a one-of-a-kind platform and novel candidates for major indications, Vaxxinity wants to disrupt the industry’s paradigm of success. 

    By Jan. 14, 2022
  • man in suit patient figures magnifying glass
    Image attribution tooltip
    Retrieved from Google image.
    Image attribution tooltip
    Opinion

    Pharma execs reveal the industry's most pressing issues

    Several market factors — including COVID — are driving changes and trends in the industry.

    By Taren Grom • Jan. 14, 2022
  • Image attribution tooltip
    Jack Taylor via Getty Images
    Image attribution tooltip

    Pharma M&A stagnated in 2021 — here's what could help it rebound

    There are plenty of reasons pharma could get its M&A groove back in 2022.

    By Jan. 13, 2022
  • Pharma Voice logo
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Image attribution tooltip

    Welcome to the new PharmaVoice

    A similar mission, a new format, and our plans for PharmaVoice's next chapter.

    By Davide Savenije • Jan. 13, 2022
  • women's health orange and pink
    Image attribution tooltip
    Permission granted by Copyright: <a href='https://www.123rf.com/profile_ileezhun'>ileezhun</a>
    Image attribution tooltip

    Biote CEO breaks down barriers in women's health

    Women’s health is coming into sharper focus in 2022, but getting funding is still difficult.

    By Robin Robinson • Jan. 11, 2022
  • photo of Ovid tweet
    Image attribution tooltip
    [photo]. Retrieved from Ovid Therapeutics.
    Image attribution tooltip
    Q&A

    Ovid's CEO shares his vision for rare disease developments

    Jeremy Levin, chairman and CEO of Ovid Therapeutics discusses the keys to success in rare disease innovation.

    By Kim Ribbink • Jan. 10, 2022
  • Image attribution tooltip
    Justin Sullivan/ via Getty Images
    Image attribution tooltip
    Q&A

    How the executive VP of HR at Incyte is tackling pharma's hiring woes

    In an industry undergoing rapid growth, the increasing job opening rates and limited talent pool are taking on a new level of importance.

    By Jan. 10, 2022
  • Image attribution tooltip
    Justin Sullivan via Getty Images
    Image attribution tooltip

    Australian firefighters raise funds for ALS research

    Funding for rare disease clinical trials can be a challenge, but in Australia, firefighters gear up to raise money for ALS. 

    By Kim Ribbink • Jan. 5, 2022
  • two researcher looking through microscopes
    Image attribution tooltip
    [photo]. Retrieved from Google image.
    Image attribution tooltip

    Rare disease innovation in 2022

    More companies are targeting gene therapies for rare disease treatments.

    By Kim Ribbink • Jan. 5, 2022
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    PharmaVoice 100 Who's on the List – By Category

    Who’s on the List — 2021 Indexed by Category Commanders & Chiefs Dr. Sam Agresta Foghorn Therapeutics Alisha Alaimo Biogen Shideh Bina Insigniam Dr. Norbert Bischofberger Kronos Bio Dr. James Kyle Bryan IQVIA Biotech Victor Bultó Novartis Pharmaceuticals Dr. Tony ...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    Entrepreneurs

    These visionary leaders recognized an opportunity to fill an industry need and are successfully leading their companies to new heights. Do you have CLAS? (Culturally and Linguistically Appropriate Strategies) Igniting change by… Having courageous conversations about race, ethnicity...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    Change Agents

    These forward-thinking individuals are disrupting the status quo and setting the strategic direction for their companies to capitalize on the opportunities that will shape the future of the healthcare ecosystem. Put people first, the rest will follow Sparking innovation by… collabor...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    2021 Red Jacket Honorees

    Inspiring leaders for today and tomorrow Since launching the Red Jacket Award in 2014, PharmaVOICE has recognized 40 inspiring, innovative, collaborative, and transformative individuals who epitomize leadership for today and tomorrow. One of the criteria for being named a Red Jacket — our version...

    By PharmaVoice Team • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    Red Jacket Ahsan Awan

    A man of many talents Sparking innovation by… creating a world that works for everyone Ahsan A. Awan Title: VP of Clinical Development Company: Genlantis Diagnostics Education: J.D., University of Oregon School of Law; M.S.Pharm., Pharmacy, Pharmacoeconomics, University of Florid...

    By Ahsan Awan • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    Red Jacket Jack Barrette

    Giving a voice to patient advocates Sparking innovation by… powering human connections for a healthier world Jack Barrette Title: Chief Innovation Officer, Health Union (formerly Founder & CEO of WEGO Health) Company: Health Union Education: B.A., English Industry Awards: Ph...

    By Jack Barrette • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    Red Jacket Olivier Chateau

    Redefining social health Blazing new trails by… innovating online communities Olivier Chateau Title: Co-Founder and CEO Company: Health Union Industry Awards: PharmaVOICE 100, 2018, 2009; EY Entrepreneur of the Year Award, 2020 Company Awards: Inc.’s Best Workplaces; Forbe...

    By Olivier Chateau • Aug. 1, 2021
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip
    Profile

    Red Jacket Laurie Cooke

    A leader of leaders Blazing new trails by… advancing gender parity and equity Laurie Cooke, RPh Title: President and CEO Company: Healthcare Businesswomen’s Association Education: PG Dip, Software Engineering Management, University of Luton; Advanced Degree, Pharmacy, Unive...

    By Laurie Cooke • Aug. 1, 2021